Compare · CERS vs WIT
CERS vs WIT
Side-by-side comparison of Cerus Corporation (CERS) and Wipro Limited (WIT): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both CERS and WIT operate in EDP Services (Technology), so they compete in similar markets.
- WIT is the larger of the two at $40.50B, about 46.7x CERS ($866.5M).
- Over the past year, CERS is up 47.8% and WIT is down 28.2% - CERS leads by 75.9 points.
- WIT has been more active in the news (12 items in the past 4 weeks vs 4 for CERS).
- WIT has more recent analyst coverage (23 ratings vs 3 for CERS).
- Company
- Cerus Corporation
- Wipro Limited
- Price
- $1.98+4.49%
- $2.04+0.99%
- Market cap
- $866.5M
- $40.50B
- 1M return
- +7.03%
- -2.39%
- 1Y return
- +47.76%
- -28.17%
- Industry
- EDP Services
- EDP Services
- Exchange
- NASDAQ
- NYSE
- IPO
- 1997
- News (4w)
- 4
- 12
- Recent ratings
- 3
- 23
Cerus Corporation
Cerus Corporation, a biomedical products company, focuses on developing and commercializing the INTERCEPT Blood System to enhance blood safety. Its INTERCEPT Blood System, a proprietary technology for controlling biological replication that is designed to reduce blood-borne pathogens in donated blood components intended for transfusion. The company offers INTERCEPT Blood Systems for platelets and plasma, which is designed to inactivate blood-borne pathogens in platelets and plasma donated for transfusion; INTERCEPT Blood System for red blood cells to inactivate blood-borne pathogens in red blood cells donated for transfusion; and INTERCEPT Blood System for Cryoprecipitation that uses its plasma system to produce pathogen reduced cryoprecipitated fibrinogen complex for the treatment and control of bleeding, including massive hemorrhage associated with fibrinogen deficiency, as well as pathogen reduced plasma, cryoprecipitate reduced. It sells platelet and plasma systems through its direct sales force and distributors in the United States, Europe, the Commonwealth of Independent States, the Middle East, Latin America, and internationally. Cerus Corporation has collaboration with LifeSouth Community Blood Centers to manufacture INTERCEPT Fibrinogen Complex. The company was incorporated in 1991 and is headquartered in Concord, California.
Wipro Limited
Wipro Limited operates as an information technology (IT), consulting, and business process services company worldwide. It operates through three segments: IT Services, IT Products, and India State Run Enterprise Services (ISRE). The IT Services segment offers IT and IT-enabled services, including digital strategy advisory, customer-centric design, technology consulting, IT consulting, custom application design, development, re-engineering and maintenance, systems integration, package implementation, infrastructure, analytics, business process, research and development, and hardware and software design services to enterprises. It serves customers in various industry sectors, such as healthcare and medical devices, consumer goods and life sciences, retail, transportation and services, communications, media and information services, technology products and platforms, banking, financial services and insurance, manufacturing, hi-tech, energy, and utilities. The IT Products segment provides a range of third-party IT products comprising enterprise platforms, networking solutions, software and data storage products, contact center infrastructure, enterprise security, IT optimization technologies, video solutions, and end-user computing solutions. It serves enterprises in various industries primarily in the India market, which comprise the government, defense, IT and IT-enabled services, telecommunications, manufacturing, utilities, education, and financial services sectors. The ISRE segment offers IT services to entities and/or departments owned or controlled by the Government of India and/or various Indian State Governments. Wipro Limited has a collaboration agreement with FEV Europe GmbH to develop and market software defined vehicles. The company was incorporated in 1945 and is based in Bengaluru, India.
Latest CERS
- SEC Form DEFA14A filed by Cerus Corporation
- SEC Form DEF 14A filed by Cerus Corporation
- Cerus Corporation filed SEC Form 8-K: Leadership Update, Financial Statements and Exhibits
- Cerus Corporation to Release First Quarter 2026 Financial Results on April 30, 2026
- SEC Form 4 filed by Green Kevin Dennis
- SEC Form 4 filed by Jensen Chrystal
- Amendment: SEC Form SCHEDULE 13G/A filed by Cerus Corporation
- Chief Legal Officer Jensen Chrystal sold $187,277 worth of shares (113,008 units at $1.66), decreasing direct ownership by 11% to 946,131 units (SEC Form 4)
- Chief Operating Officer Jayaraman Vivek K sold $273,769 worth of shares (165,200 units at $1.66), decreasing direct ownership by 9% to 1,747,674 units (SEC Form 4)
- President and CEO Greenman William Mariner sold $742,023 worth of shares (447,757 units at $1.66), decreasing direct ownership by 8% to 4,998,493 units (SEC Form 4)
Latest WIT
- SEC Form F-X filed by Wipro Limited
- SEC Form CB filed by Wipro Limited
- SEC Form 6-K filed by Wipro Limited
- SEC Form 6-K filed by Wipro Limited
- SEC Form 6-K filed by Wipro Limited
- SEC Form 6-K filed by Wipro Limited
- Wipro Announces Results for the Quarter and Year Ended March 31, 2026
- Wipro Hydraulics Signs Definitive Agreement With Indeco to Expand Product Offerings
- CORRECTING and REPLACING Wipro Limited to Announce Results for the Fourth Quarter Ended March 31, 2026, on April 16, 2026
- SEC Form 6-K filed by Wipro Limited